Preventing adverse sequelae of bacterial vaginosis -: A public health program and research agenda

被引:82
作者
Koumans, EH
Kendrick, JS
机构
[1] Ctr Dis Control & Prevent, Div STD Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA
[2] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA
关键词
D O I
10.1097/00007435-200105000-00011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The cause of bacterial vaginosis remains poorly understood, Recent evidence strengthens the association between bacterial vaginosis and serious medical complications, Goal: To review the evidence linking bacterial vaginosis with adverse pregnancy outcomes, complications after gynecologic procedures, and HIV infection, and to identify prevention strategies. Methods: In March 1999. the Centers for Disease Control and Prevention organized a conference to accomplish this goal. Results: Better understanding is needed concerning the etiology, epidemiology, and natural history of bacterial vaginosis, More efficacious treatment of bacterial vaginosis and strategies to reduce maternal complications associated with bacterial vaginosis, such as premature rupture of the fetal membranes, chorioamnionitis, premature labor and delivery, postdelivery endometritis, and postpartum infant complications should be developed. Recent evidence shows that screening and treatment of bacterial vaginosis before abortion reduces postabortion pelvic inflammatory disease, and that anaerobic coverage during hysterectomy reduces postoperative complications. Better understanding concerning the relation of bacterial vaginosis to acquisition of sexually transmitted diseases and HIV infection are needed as well as possible prevention strategies. Conclusions: A national prevention effort should be guided by the results of research that addresses current knowledge gaps.
引用
收藏
页码:292 / 297
页数:6
相关论文
共 63 条
  • [1] Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis.
    Carey, JC
    Klebanoff, MA
    Hauth, JC
    Hillier, SL
    Thom, EA
    Ernest, JM
    Heine, RP
    Nugent, RP
    Fischer, ML
    Leveno, KJ
    Wapner, R
    Varner, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08) : 534 - 540
  • [2] Immunoglobulin A response against Gardnerella vaginalis hemolysin and sialidase activity in bacterial vaginosis
    Cauci, S
    Driussi, S
    Monte, R
    Lanzafame, P
    Pitzus, E
    Quadrifoglio, F
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (03) : 511 - 515
  • [3] Impairment of the mucosal immune system: IgA and IgM cleavage detected in vaginal washings of a subgroup of patients with bacterial vaginosis
    Cauci, S
    Monte, R
    Driussi, S
    Lanzafame, P
    Quadrifoglio, F
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06) : 1698 - 1706
  • [4] *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P70
  • [5] BACTERIAL VAGINOSIS AND HIV SEROPREVALENCE AMONG FEMALE COMMERCIAL SEX WORKERS IN CHIANG-MAI, THAILAND
    COHEN, CR
    DUERR, A
    PRUITHITHADA, N
    RUGPAO, S
    HILLIER, S
    GARCIA, P
    NELSON, K
    [J]. AIDS, 1995, 9 (09) : 1093 - 1097
  • [6] Dammann O, 1997, DEV MED CHILD NEUROL, V39, P836, DOI 10.1111/j.1469-8749.1997.tb07554.x
  • [7] Eschenbach D A, 1984, Scand J Urol Nephrol Suppl, V86, P213
  • [8] ESCHENBACH DA, 1989, OBSTET GYN CLIN N AM, V16, P593
  • [9] SINGLE-DOSE INTRAVENOUS TINIDAZOLE PROPHYLAXIS IN ABDOMINAL HYSTERECTOMY
    EVALDSON, GR
    LINDGREN, S
    MALMBORG, AS
    NORD, CE
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1986, 65 (04) : 361 - 365
  • [10] VAGINAL FLORA AND PELVIC INFLAMMATORY DISEASE
    FARO, S
    MARTENS, M
    MACCATO, M
    HAMMILL, H
    PEARLMAN, M
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (02) : 470 - 474